Thomas Malley - Aug 12, 2025 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Stock symbol
KNSA
Transactions as of
Aug 12, 2025
Transactions value $
-$4,044,704
Form type
4
Date filed
8/14/2025, 04:59 PM
Previous filing
Jun 6, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Malley Thomas Director 23 OLD BOND STREET, THIRD FLOOR, LONDON, UNITED KINGDOM /s/ Madelyn Zeylikman, Attorney-in-Fact 2025-08-14 0001403322

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Shares Options Exercise $40.8K +22K +175.03% $1.86 34.5K Aug 12, 2025 Direct
transaction KNSA Class A Ordinary Shares Options Exercise $104K +27.4K +79.55% $3.80 62K Aug 12, 2025 Direct
transaction KNSA Class A Ordinary Shares Sale -$1.6M -49.4K -79.75% $32.40 12.5K Aug 12, 2025 Direct F1
transaction KNSA Class A Ordinary Shares Options Exercise $209K +20.1K +160.44% $10.36 32.7K Aug 13, 2025 Direct
transaction KNSA Class A Ordinary Shares Options Exercise $296K +30K +91.81% $9.88 62.7K Aug 13, 2025 Direct
transaction KNSA Class A Ordinary Shares Sale -$1.67M -50.1K -79.98% $33.32 12.5K Aug 13, 2025 Direct F2
transaction KNSA Class A Ordinary Shares Options Exercise $290K +18.8K +149.53% $15.47 31.3K Aug 14, 2025 Direct
transaction KNSA Class A Ordinary Shares Options Exercise $476K +33.2K +106.17% $14.33 64.5K Aug 14, 2025 Direct
transaction KNSA Class A Ordinary Shares Options Exercise $399K +26.2K +40.65% $15.19 90.8K Aug 14, 2025 Direct
transaction KNSA Class A Ordinary Shares Sale -$2.59M -78.2K -86.18% $33.09 12.5K Aug 14, 2025 Direct F3
holding KNSA Class A Ordinary Shares 72K Aug 12, 2025 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Share Option Options Exercise $0 -22K -100% $0.00 0 Aug 12, 2025 Class A Ordinary Shares 22K $1.86 Direct F5
transaction KNSA Share Option Options Exercise $0 -27.4K -100% $0.00 0 Aug 12, 2025 Class A Ordinary Shares 27.4K $3.80 Direct F5
transaction KNSA Share Option Options Exercise $0 -20.1K -100% $0.00 0 Aug 13, 2025 Class A Ordinary Shares 20.1K $10.36 Direct F5
transaction KNSA Share Option Options Exercise $0 -30K -100% $0.00 0 Aug 13, 2025 Class A Ordinary Shares 30K $9.88 Direct F5
transaction KNSA Share Option Options Exercise $0 -18.8K -100% $0.00 0 Aug 14, 2025 Class A Ordinary Shares 18.8K $15.47 Direct F5
transaction KNSA Share Option Options Exercise $0 -33.2K -100% $0.00 0 Aug 14, 2025 Class A Ordinary Shares 33.2K $14.33 Direct F5
transaction KNSA Share Option Options Exercise $0 -26.2K -100% $0.00 0 Aug 14, 2025 Class A Ordinary Shares 26.2K $15.19 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.06 and $32.685. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F2 This transaction was executed in multiple trades through a broker-dealer at prices ranging between $33.1301 and $33.50. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F3 This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.82 and $33.41. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F4 Mr. Malley is the president of Mossrock Capital, LLC (Mossrock) and may be deemed to beneficially own the shares owned by Mossrock.
F5 The option is fully vested and exercisable.